2025-11-14T11:16:46-06:00 2024-12-31 333709623 COHNREZNICK ADVISORY LLC 1301 AVENUE OF THE AMERICAS NEW YORK NY 10019 990 2024-01-01 521752653 CARDIOVASCULAR RESEARCH FOUNDATION CARD 6464344691 1700 BROADWAY NEW YORK NY 10019 EILEEN MORALES TREASURER & CFO 6464344691 2025-11-12 1 1 LORI ROTHE YOKOBOSKY P01273422 2122970400 2025-11-11 2024 2025-03-06 01:10:19Z JUAN FGRANADA MD 1700 BROADWAY NEW YORK NY 10019 79177393 0 X WWW.CRF.ORG X 1991 DC CARDIOVASCULAR RESEARCH FOUNDATION IS AN INDEPENDENT, ACADEMICALLY FOCUSED ORGANIZATION DEDICATED TO IMPROVING THE SURVIVAL AND QUALITY OF LIFE FOR PEOPLE WITH CARDIOVASCULAR DISEASE THROUGH RESEARCH AND EDUCATION. THE ORGANIZATION HAS PLAYED A MAJOR ROLE IN REALIZING DRAMATIC IMPROVEMENTS IN THE LIVES OF COUNTLESS NUMBERS OF PATIENTS BY ESTABLISHING THE SAFE USE OF NEW TECHNOLOGIES AND THERAPIES IN THE SUBSPECIALTY OF INTERVENTIONAL CARDIOLOGY AND ENDOVASCULAR MEDICINE. 11 10 213 10 0 0 8046413 7422106 61630902 59958634 2257238 1650798 6336676 -127212 78271229 68904326 800000 1000000 0 0 25248131 26821269 0 0 43034 38923629 38834629 64971760 66655898 13299469 2248428 91969884 87491417 45544170 37248809 46425714 50242608 X TO HELP DOCTORS IMPROVE THE SURVIVAL AND QUALITY OF LIFE FOR PEOPLE SUFFERING FROM HEART AND VASCULAR DISEASE THROUGH INNOVATION, INVESTIGATION AND EDUCATION. 0 0 19084666 370000 25769626 CLINICAL TRIALS CENTER - A DISTINGUISHED ACADEMIC RESEARCH ORGANIZATION, THE CRF CLINICAL TRIALS CENTER (CTC) PLANS AND EXECUTES CLINICAL INVESTIGATIONS FROM FIRST-IN-MAN STUDIES TO LARGE, MULTICENTER INTERNATIONAL TRIALS DESIGNED TO GAIN INSIGHTS THAT WILL ELEVATE THE QUALITY OF CARE IN CARDIOVASCULAR MEDICINE. THE CTC SPECIALIZES IN TRIAL DESIGN, EVENT ADJUDICATION, DATA AND SAFETY MONITORING, AND BIO STATISTICAL SERVICES. CRF FACULTY AUTHOR OVER 300 ARTICLES ANNUALLY IN PRESTIGIOUS MEDICAL AND SCIENTIFIC JOURNALS, BRINGING THE LATEST RESEARCH TO THE GLOBAL MEDICAL COMMUNITY. 6285209 190000 7560409 SKIRBALL CENTER FOR INNOVATION - A STATE OF THE ART INNOVATION CENTER, THE CRF SKIRBALL CENTER FOR INNOVATION IS DEDICATED TO THE INVESTIGATION AND VALIDATION OF NOVEL CONCEPTS, TREATMENTS, AND DEVICES. OUR PREEMINENT TEAM OF PIONEERING RESEARCHERS AND THOUGHT LEADERS CONTINUALLY BREAK NEW GROUND AS THEY GUIDE EARLY IDEAS AND INVENTIONS THROUGH COMPREHENSIVE PRECLINICAL RESEARCH PROGRAMS TO INTRODUCE PRACTICAL THERAPIES INTO CLINICAL MEDICINE. 10835512 307500 17901710 TCT 2024 (TRANSCATHETER CARDIOVASCULAR THERAPEUTICS) MEETING - THE CARDIOVASCULAR RESEARCH FOUNDATION (CRF) STANDS AT THE FOREFRONT OF EDUCATION IN CARDIOVASCULAR MEDICINE. THIS FOCUS REFLECTS THE CRF FACULTY'S COMMITMENT TO SHARING AND DISSEMINATING THE LATEST CLINICAL RESEARCH INFORMATION TO THE BROADEST AUDIENCE AT THE EARLIEST POSSIBLE DATE. THE FUNDAMENTAL GOAL OF CRF'S EDUCATION PROGRAM IS TO ENABLE THE GLOBAL PHYSICIAN COMMUNITY TO APPLY IMPORTANT NEW KNOWLEDGE TO ACTUAL PATIENT CARE. CRF'S PRINCIPAL ANNUAL EDUCATIONAL EVENT, TRANSCATHETER CARDIOVASCULAR THERAPEUTICS (TCT) MEETING, IS THE WORLD'S LARGEST EDUCATIONAL MEETING DEDICATED TO THE FIELD OF INTERVENTIONAL VASCULAR THERAPY. THIS IS THE SHOWCASE EDUCATIONAL EVENT IN THE CARDIOVASCULAR FIELD AND IS USED TO EDUCATE AND EXCHANGE STUDY FINDINGS AND TO IMPROVE TREATMENT OF PATIENTS WHO HAVE CARDIOVASCULAR DISEASE. 22136676 132500 8728889 OTHER - INCLUDES WEB SERVICES, OTHER SMALL MEETINGS, AND SUPPORT FUNCTIONS TO EACH OF THE DIVISIONS ABOVE. 22136676 132500 8728889 58342063 1 1 0 0 0 0 0 0 0 0 1 0 0 0 1 1 0 1 0 1 1 0 0 1 1 0 0 1 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 198 0 1 213 1 0 0 0 0 0 1 1 0 0 0 0 0 0 X 11 10 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 NY CA MA PA X EILEEN MORALES 6464344691 1700 BROADWAY NEW YORK NY 10019 COLETTE Y GARDNER DIRECTOR 2.00 X 0 0 0 ERIC B WOLDENBERG CHAIRMAN 2.00 X X 0 0 0 FRANK LITVACK MD DIRECTOR 2.00 X 0 0 0 JEFFREY W MOSES MD DIRECTOR 2.00 X 0 0 0 JOSEPH G BECK DIRECTOR 2.00 X 0 0 0 JUAN F GRANADA MD CEO & DIRECTOR 37.50 X X 933460 0 69098 KAREN G KRASNEY DIRECTOR 2.00 X 0 0 0 MARTIN B LEON MD DIRECTOR 2.00 X 0 0 0 MARVIN L WOODALL DIRECTOR 2.00 X 0 0 0 TERESA LESTE DIRECTOR 2.00 X 0 0 0 WILLIAM A HIMMELSBACH DIRECTOR 2.00 X 0 0 0 DONALD L ABRAMS CHIEF LEGAL OFFICER 37.50 X 482912 0 27346 EILEEN MORALES CFO 37.50 X 474963 0 38684 ALEXANDRA POPMA DIRECTOR 37.50 X 461897 0 23000 DANIEL BURKOFF DIRECTOR OF HEART FAILURE 37.50 X 315075 0 56665 DAVID COHEN DIRECTOR OF CLINICAL & OUT 37.50 X 700158 0 36515 GRZEGORZ KALUZA DIRECTOR RESEARCH 37.50 X 325318 0 66884 TRICIA RAWH EXECUTIVE DIRECTOR, CED 37.50 X 431480 0 23012 4125263 0 341204 86 0 1 0 GARY S MINTZ MD LLC 822 EAST CAPITOL STREET NE WASHINGTON DC 20003 MANAGEMENT CONSULTING 310000 LISSOM CORP 1801 SO FLAGER DRIVE - APT 1809 WEST PALM BEACH FL 33401 MANAGEMENT CONSULTING 201093 FIXED GEAR DESIGNS 2917 ANNUNCIATION STREET NEW ORLEANS LA 70115 MANAGEMENT CONSULTING 179393 VERY FINE WORK 275 JEFFERSON AVENUE - APT 6 BROOKLYN NY 11261 MANAGEMENT CONSULTING 155870 MATTTHEW SCHWARTZ DESIGN STUDIO LLC 82 NASSAU STREET - 909 NEW YORK NY 10038 MANAGEMENT CONSULTING 140000 9 565500 6856606 7422106 INVESTIGATIONAL RESEARCH 541700 33453909 33453909 EDUCATION & TRAINING 541700 26504725 26504725 59958634 1574405 1574405 10156688 10080295 76393 76393 76393 63560 565500 192772 -129212 -129212 2000 2000 2000 68904326 59960634 0 1521586 X 1000000 1000000 2026463 1613921 412542 20987745 16682239 4305506 491110 401900 89210 1668478 1365401 303077 1647473 1348211 299262 168507 168507 187322 187322 54516 54516 8013388 7573388 440000 67277 67277 534642 448193 86316 133 3395472 2943878 451594 1595556 1518097 77459 17574024 17533116 9254 31654 531538 518400 13138 997697 923503 74194 572914 479697 93217 REPAIRS AND MAINTENANCE 2680525 1767020 913427 78 PROCUREMENT 1157392 1157392 FEES AND LICENSES 448171 373834 67932 6405 STAFF TRAINING 245688 109604 135784 300 610000 516992 88544 4464 66655898 58342063 8270801 43034 13422752 7616305 14944760 13766231 15485969 13076045 2306356 2512825 35264178 27365112 8225464 7899066 16103554 24355014 32591 32566 16646673 14759603 4801765 3473762 91969884 87491417 13079582 8185232 2489270 2057939 10510001 9600000 19465317 17405638 45544170 37248809 X 46425714 50242608 46425714 50242608 91969884 87491417 2248428 1568466 0 X 0 1 X 1 0 X 5605353 13101589 7867579 8046413 7422106 42043040 30619135 38478693 52856326 61630902 59958634 243543690 36224488 51580282 60723905 69677315 67380740 285586730 1000 40500 19500 20000 81000 0 1000 40500 19500 20000 81000 285505730 341295 386441 393037 980391 1574405 3675569 341295 386441 393037 980391 1574405 3675569 611911 2485 26140 6500000 2000 7142536 37177694 51969208 61143082 77157706 68957145 296404835 0.96320 0.96700 0.01240 0.00740 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: OTHER INCOME - 2020 AMOUNT: $ 32,928. 2022 AMOUNT: $ 2,250. 2024 AMOUNT: $ 2,000. TRAVEL REIMBURSEMENT - 2020 AMOUNT: $ 21,112. 2021 AMOUNT: $ 2,485. 2022 AMOUNT: $ 849. BAD DEBT RECOVERY - 2020 AMOUNT: $ 233,073. PARTNERSHIP K-1 GAIN - 2020 AMOUNT: $ 324,798. 2022 AMOUNT: $ 23,041. SETTLEMENT PROCEEDS - 2023 AMOUNT: $ 6,500,000. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 312940 312940 8017725 3598678 4419047 5260942 3031397 2229545 19609282 18697780 911502 2063289 2037257 26032 7899066 OPERATING LEASE LIABILITIES 16520787 FINANCE LEASE LIABILITIES 884851 17405638 X 71133021 1568466 521973 2090439 69042582 54516 -192772 -138256 68904326 67316127 521973 192772 714745 66601382 54516 54516 66655898 PART X, LINE 2: MANAGEMENT HAS ANALYZED THE TAX POSITIONS TAKEN BY THE CRF AND HAS CONCLUDED THAT, AS OF DECEMBER 31, 2024, THERE ARE NO UNCERTAIN TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN THAT WOULD REQUIRE RECOGNITION OF A LIABILITY (OR ASSET) OR DISCLOSURE IN THE CONSOLIDATED FINANCIAL STATEMENTS. PART XI, LINE 4B - OTHER ADJUSTMENTS: FUNDRAISING EXPENSES -192,772. PART XII, LINE 2D - OTHER ADJUSTMENTS: FUNDRAISING EXPENSES 192,772. ASIA 0 0 PROGRAM SERVICES ACTIVITIES RELATED TO CLINICAL MANAGEMENT AND RESEARCH SUPPORT 69840 CANADA 0 2 PROGRAM SERVICES ACTIVITIES RELATED TO ECDUCATION AND TRAINING 680370 EUROPE 0 0 PROGRAM SERVICES ACTIVITIES RELATED TO CLINICAL MANAGEMENT AND RESEARCH SUPPORT 793736 MIDDLE EAST 0 0 PROGRAM SERVICES ACTIVITIES RELATED TO CLINICAL MANAGEMENT AND RESEARCH SUPPORT 240834 NORTHEASTERN AFRICA 0 0 PROGRAM SERVICES ACTIVITIES RELATED TO CLINICAL MANAGEMENT AND RESEARCH SUPPORT 20750 NORTH AMERICA 0 0 PROGRAM SERVICES ACTIVITIES RELATED TO CLINICAL MANAGEMENT AND RESEARCH SUPPORT 8540 SOUTH AMERICA 0 0 PROGRAM SERVICES ACTIVITIES RELATED TO CLINICAL MANAGEMENT AND RESEARCH SUPPORT 450 0 2 0 0 0 2 1814520 0 1814520 0 0 0 0 0 1 X 0 LISSOM CORP 1801 SO FLAGLER DRIVE 1809 WEST PALM BEACH FL 33401 PULSE OF THE CITY GALA (FUNDRAISING EVENT) 0 629060 40219 588841 629060 40219 588841 NY CA MA PA GALA 629060 565500 63560 62904 28074 101794 629060 565500 63560 62904 28074 101794 192772 -129212 1 COLUMBIA UNIVERSITY COLLEGE OF PHYSICIANS AND SURGEONS 622 WEST 168TH STREET NEW YORK NY 10032 135598093 501(C)(3) 1000000 0 CLINICAL RESEARCH IN THE FIELD OF CARDIOVASCULAR MEDICINE 1 PART I, LINE 2: USE OF GRANT FUNDS FOR CLINICAL RESEARCH ARE STIPULATED IN THE GRANTS AGREEMENT. 1 X X X X 0 0 0 0 0 0 0 1 0 JUAN F GRANADA MD CEO & DIRECTOR 682494 0 250000 0 966 0 30500 0 38598 0 1002558 0 0 0 DAVID COHEN DIRECTOR OF CLINICAL & OUT 606082 0 91304 0 2772 0 30499 0 6016 0 736673 0 0 0 EILEEN MORALES CFO 392318 0 82022 0 623 0 23000 0 15684 0 513647 0 0 0 DONALD L ABRAMS CHIEF LEGAL OFFICER 479712 0 0 0 3200 0 24146 0 3200 0 510258 0 0 0 ALEXANDRA POPMA DIRECTOR 386294 0 75000 0 603 0 23000 0 0 0 484897 0 0 0 TRICIA RAWH EXECUTIVE DIRECTOR, CED 357967 0 73142 0 371 0 23000 0 12 0 454492 0 0 0 GRZEGORZ KALUZA DIRECTOR RESEARCH 323844 0 0 0 1474 0 27076 0 39808 0 392202 0 0 0 DANIEL BURKOFF DIRECTOR OF HEART FAILURE 312667 0 0 0 2408 0 30500 0 26165 0 371740 0 0 0 PART I, LINE 7 AMOUNTS INCLUDED ON PART II, COLUMN B(II), REPRESENT BONUSES THAT WERE APPROVED BY THE BOARD, THESE AMOUNTS WERE INCLUDED IN THE INDIVIDUAL'S W-2. A COUNTY OF ROCKLAND INDUSTRIAL DEVELOPMENT AGENCY 773557AH6 2004-12-23 18000000 TO BUILD RESEARCH FACILITY IN ROCKLAND COUNTY, NEW YORK 0 0 0 A 8400000 18000000 109201 17890799 4652810 2005 0 0 0 0 A 0 0 0 0 0 0 0 0 1 A 1 FORM 990, PART VI, SECTION B, LINE 11B THE TAX RETURN IS PREPARED BY AN INDEPENDENT ACCOUNTING FIRM BASED ON THE INFORMATION PROVIDED BY THE CARDIOVASCULAR RESEARCH FOUNDATION. PRIOR TO FILING, THE BOARD OF DIRECTORS RECEIVES A COPY OF FORM 990 AND THE ATTACHMENTS TO REVIEW AND DISCUSS. THE ACCOUNTING FIRM RESPONDS TO VARIOUS QUESTIONS ASKED BY THE BOARD PRIOR TO SUBMISSION TO THE IRS. FORM 990, PART VI, SECTION B, LINE 12C THE BOARD OF DIRECTORS AND CORPORATE OFFICERS ARE REQUIRED TO RESPOND TO INQUIRIES ABOUT THE CONFLICT OF INTEREST POLICY AND DISCLOSE ANY CONFLICTS ON AN ANNUAL BASIS. THEY ALSO HAVE TO COMPLETE AN ANNUAL ONLINE QUESTIONNAIRE. IN THE EVENT THAT A CONFLICT IS IDENTIFIED, THE PERSON HAVING THE CONFLICT IS REQUIRED TO RECUSE THEMSELVES FROM ANY DECISION MAKING ASPECTS OF THE RELATED ISSUE AND DECISIONS ARE MADE BY THE BOARD OF DIRECTORS WITHOUT THE VOTE OF THE CONFLICTED MEMBER. CONFLICTS ARE MONITORED BY THE CHIEF LEGAL OFFICER, WHO ALSO SERVES AS THE CARDIOVASCULAR RESEARCH FOUNDATION'S COMPLIANCE OFFICER. FORM 990, PART VI, SECTION B, LINE 15 THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS REVIEWS THE COMPENSATION OF THE OFFICERS TO DETERMINE IF THE COMPENSATION IS REASONABLE, BASED UPON THE REVIEW OF FORMS 990 FOR OTHER TAX-EXEMPT ORGANIZATIONS WITH EXEMPT PURPOSE'S SIMILAR TO THE CARDIOVASCULAR RESEARCH FOUNDATION'S MISSION. COMPARATIVE INFORMATION IS OBTAINED FROM THE PHARMACEUTICAL AND DEVICE INDUSTRIES AND OTHER NOT-FOR-PROFITS IN THE NEW YORK CITY AREA. COMPENSATION IS ALSO BASED UPON EDUCATIONAL AND WORK EXPERIENCE. THE CEO HAS AN EMPLOYMENT CONTRACT. FORM 990, PART VI, SECTION C, LINE 19 THE DOCUMENTS ARE AVAILABLE BY REQUEST. FORM 990, PART IX, LINE 11G CONSULTANTS & SUBCONTRACTORS: PROGRAM SERVICE EXPENSES 7,573,388. MANAGEMENT AND GENERAL EXPENSES 440,000. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 8,013,388. INNOVATION ALLIANCE GROUP LLC 1700 BROADWAY NEW YORK NY 10019 833210717 INVESTMENT NY N/A INVESTMENT 0 1 0.50000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0